Enveric Biosciences, Inc. — Form D

Enveric Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-04. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (58)

Showing 25 of 58 people.

NameRoleLocation
Kevin M. CoveneyRelated PersonCambridge, MA
Sheila DeWittRelated PersonCambridge, MA
George W. KeglerRelated PersonCambridge, MA
Frank PasqualoneRelated PersonCambridge, MA
Michael SchabackerRelated PersonCambridge, MA
Joseph E. TuckerRelated PersonCambridge, MA
Michael D. WebbRelated PersonCambridge, MA
David JohnsonDirectorGreenwood Village, CO
David JohnsonExecutive OfficerGreenwood Village, CO
Sheila W DeWittDirectorCambridge, MA
George W KeglerDirectorCambridge, MA
Kevin M CoveneyExecutive OfficerCambridge, MA
Marcus W SchabackerDirectorCambridge, MA
Frank W PasqualoneDirectorCambridge, MA
Michael D WebbDirectorCambridge, MA
Joseph E TuckerDirectorCambridge, MA
Joseph E TuckerExecutive OfficerCambridge, MA
David LuciDirectorJersey City, NJ
VIRAJ PATELExecutive OfficerSeattle, WA
Dimitrios AngelisDirectorDenver, CO
Brent KeltonExecutive OfficerAustin, TX
Joseph TuckerDirectorNaples, FL
Joseph TuckerExecutive OfficerNaples, FL
Bob DagherExecutive OfficerNaples, FL
Marcus SchabackerDirectorNaples, FL

Other filings by this issuer (9)

FiledFormOfferingSold
2026-02-11D$1.5M$1.5M
2025-12-23D$107K$107K
2025-10-03D
2023-04-19D/A$12.8M$12.8M
2022-08-05D$8.6M$8.6M
2021-02-24D$8.4M
2021-01-20D$8.2M
2018-08-28D/A$6.6M$6.6M
2018-08-02D$6.0M$6.0M

More